Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension
- PMID: 30370079
- PMCID: PMC6186633
- DOI: 10.21037/jtd.2018.08.134
Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension
Conflict of interest statement
Conflicts of Interest: Sho Torii receives research grants from SUNRISE lab. Renu Virmani and Aloke V. Finn have received institutional research support from Abbott Vascular, Boston Scientific, Cook Medical, Cardiovascular Systems, Inc., Medtronic, ReCor Medical, and Terumo Corporation; Renu Virmani is a consultant for 480 Biomedical, Abbott Vascular, Medtronic, and W.L. Gore. The other authors have no conflicts of interest to declare.
Figures


Comment on
-
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Lancet. 2018. PMID: 29803590 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources